| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76557-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB100-63026-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76290-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB100-65535-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB120-6406-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76441SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41295-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65362-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76774-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43426-0.025mg | |||
![Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the PE/Cy5 conjugate of NBP1-43384. Staining of normal human peripheral blood cells with PE-Cy5 Mouse IgG1 kappa Isotype Control (open histogram) orAnti-Human CD80 (B7-1) PE-Cy5 (filled histogram).](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-2D10-4-Flow-Cytometry-NBP1-43384-img0006.jpg "Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the PE/Cy5 conjugate of NBP1-43384. Staining of normal human peripheral blood cells with PE-Cy5 Mouse IgG1 kappa Isotype Control (open histogram) orAnti-Human CD80 (B7-1) PE-Cy5 (filled histogram).")
![Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the FITC conjugate of NBP1-43384. Staining of the Daudi cell line with Mouse IgG1 kappa Isotype Control FITC (cat. 11-4714) (blue histogram) or Anti-Human CD80 (B7-1) FITC (purple histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-2D10-4-Flow-Cytometry-NBP1-43384-img0004.jpg)
![Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the PE conjugate of NBP1-43384. Analysis of human peripheral blood leukocytes using CD80 PE conjugage. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8 cells/test.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-2D10-4-Flow-Cytometry-NBP1-43384-img0005.jpg)
![Western Blot: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody [NBP1-76557] - 293 cell lysate with Lymphocyte Antigen 9 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-Western-Blot-NBP1-76557-img0001.jpg "Western Blot: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody [NBP1-76557] - 293 cell lysate with Lymphocyte Antigen 9 antibody at (A) 1 and (B) 2 ug/mL.")
![Immunocytochemistry/ Immunofluorescence: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody - BSA Free [NBP1-76557] - Immunocytochemistry of CD229/SLAMF3/Lymphocyte Antigen 9 in 293 cells with CD229/SLAMF3/Lymphocyte Antigen 9 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76557_rabbit-polyclonal-cd229-slamf3-lymphocyte-antigen-9-antibody-271120242042544.jpg)
![Immunocytochemistry/ Immunofluorescence: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody - BSA Free [NBP1-76557] - Immunofluorescence of CD229/SLAMF3/Lymphocyte Antigen 9 in 293 cells with CD229/SLAMF3/Lymphocyte Antigen 9 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76557_rabbit-polyclonal-cd229-slamf3-lymphocyte-antigen-9-antibody-2711202419313292.jpg)
![Immunohistochemistry: NLRP7 Antibody - BSA Free [NBP1-76290] - Immunohistochemistry of NLRP7 in human brain tissue with NLRP7 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76290_rabbit-polyclonal-nlrp7-antibody-271120242013188.jpg "Immunohistochemistry: NLRP7 Antibody - BSA Free [NBP1-76290] - Immunohistochemistry of NLRP7 in human brain tissue with NLRP7 antibody at 10 u/mL.")
![Immunocytochemistry/ Immunofluorescence: NLRP7 Antibody - BSA Free [NBP1-76290] - Immunofluorescence of NLRP7 in human brain tissue with NLRP7 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-76290_rabbit-polyclonal-nlrp7-antibody-2711202419353830.jpg)
![Western Blot: NLRP7 Antibody [NBP1-76290] - Analysis of NALP7 in K562 cell lysate with NALP7 antibody at 2 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/NLRP7-Antibody-Western-Blot-NBP1-76290-img0006.jpg)
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of representative areas of synovial tissue samples taken from patients with end-stage osteoarthritis (OA) or refractory rheumatoid arthritis (RA) is shown. Expression pattern and staining intensity of RA samples represent the stronger intensity of synovial inflammation when compared with OA samples.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0003.jpg "Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of representative areas of synovial tissue samples taken from patients with end-stage osteoarthritis (OA) or refractory rheumatoid arthritis (RA) is shown. Expression pattern and staining intensity of RA samples represent the stronger intensity of synovial inflammation when compared with OA samples.")
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of activation markers in synovial membranes of osteoarthritis. Phenotypic markers that are instrumental in extracellular matrix alteration are detectable only at a low level (MMP-1, CD44v7/8) in areas that are slightly FAP-positive. FAP, fibroblast activation protein; MMP, matrix metalloproteinase.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0001.jpg)
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of activation markers in synovial membranes of rheumatoid arthritis. Expression of fibroblast activation protein (FAP) is accompanied by accumulation of activation markers (MMP-1 and MMP-13) and splice variants of CD44 (v3 and v7/8) that are known to correlate with the degree of inflammation and that are involved in extracellular matrix deposition.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0002.jpg)
![Flow Cytometry: CD45RC Antibody (OX22) [NB120-6406] - Analysis using the FITC conjugate of NB120-6406. Staining of rat spleen cells.](http://images.novusbio.com/fullsize/CD45RC-Antibody-OX22-Flow-Cytometry-NB120-6406-img0004.jpg "Flow Cytometry: CD45RC Antibody (OX22) [NB120-6406] - Analysis using the FITC conjugate of NB120-6406. Staining of rat spleen cells.")
![Flow Cytometry: CD45RC Antibody (OX22) [NB120-6406] - Analysis using the Biotin conjugate of NB120-6406. Staining of rat splenocytes.](http://images.novusbio.com/fullsize/CD45RC-Antibody-OX22-Flow-Cytometry-NB120-6406-img0003.jpg)
![Western Blot: TAK1 Antibody [NBP1-76441] - Rat thymus cell lysate with TAK1 antibody at (A) 1, (B) 2, and (C) 4 ug/ml.](http://images.novusbio.com/fullsize/TAK1-Antibody-Western-Blot-NBP1-76441-img0001.jpg "Western Blot: TAK1 Antibody [NBP1-76441] - Rat thymus cell lysate with TAK1 antibody at (A) 1, (B) 2, and (C) 4 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: TAK1 Antibody - BSA Free [NBP1-76441] - Immunofluorescence of TAK1 in Rat Thymus cells with TAK1 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76441_rabbit-polyclonal-tak1-antibody-2711202420352427.jpg)
![Western Blot: CD55/DAF Antibody [NBP2-41295] - Western blot analysis of CD55/DAF expression in HeLa cell lysate with CD55/DAF antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/CD55-DAF-Antibody-Western-Blot-NBP2-41295-img0004.jpg "Western Blot: CD55/DAF Antibody [NBP2-41295] - Western blot analysis of CD55/DAF expression in HeLa cell lysate with CD55/DAF antibody at (A) 1 and (B) 2 ug/ml.")
![Immunohistochemistry: CD55/DAF Antibody - BSA Free [NBP2-41295] - Immunohistochemistry of CD55/DAF in human lung tissue with CD55/DAF antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41295_rabbit-polyclonal-cd55-daf-antibody-271120242013263.jpg)
![Immunocytochemistry/ Immunofluorescence: CD55/DAF Antibody - BSA Free [NBP2-41295] - Immunofluorescence of CD55/DAF in human lung tissue with CD55/DAF antibody at 20 ug/ml.](http://images.novusbio.com/fullsize/antibody/nbp2-41295_rabbit-polyclonal-cd55-daf-antibody-immunocytochemistry-immunofluorescence-19122024143314..jpg)
![Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Western-Blot-NBP1-76774-img0002.jpg "Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.")
![Immunohistochemistry-Paraffin: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen tissue with BCMA antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Immunohistochemistry-Paraffin-NBP1-76774-img0005.jpg)
![Immunocytochemistry/ Immunofluorescence: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunofluorescence of BCMA/TNFRSF17 in Human Spleen tissue with BCMA/TNFRSF17 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420285861.jpg)
![Immunohistochemistry: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunohistochemistry of BCMA/TNFRSF17 in human spleen tissue with BCMA/TNFRSF17 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420414573.gif)
![Western Blot: Properdin Antibody (10-18) [NB100-64749] - Human serum was run under reducing conditions on SDS PAGE and transferred to a PVDF membrane. In lane 1, Bio-Rad Precision Plus molecular weight marker was run. In lane 2, Mouse anti Human Factor P was used as the primary antibody. HRP conjugated Goat anti Mouse IgG (H/L) was used as the secondary antibody. As a control, HRP conjugated Goat anti Mouse IgG (H/L) was run in lane 3. Visualization was carried out using the Bio-Rad ChemiDoc Imaging System with automatic exposure.](http://images.novusbio.com/fullsize/Properdin-Antibody-10-18-Western-Blot-NB100-64749-img0001.jpg "Western Blot: Properdin Antibody (10-18) [NB100-64749] - Human serum was run under reducing conditions on SDS PAGE and transferred to a PVDF membrane. In lane 1, Bio-Rad Precision Plus molecular weight marker was run. In lane 2, Mouse anti Human Factor P was used as the primary antibody. HRP conjugated Goat anti Mouse IgG (H/L) was used as the secondary antibody. As a control, HRP conjugated Goat anti Mouse IgG (H/L) was run in lane 3. Visualization was carried out using the Bio-Rad ChemiDoc Imaging System with automatic exposure.")
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy7 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy7 (open histogram) or Anti-Human CD27 PE-Cy7 (filled histogram). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0011.jpg "Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy7 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy7 (open histogram) or Anti-Human CD27 PE-Cy7 (filled histogram). Cells in the lymphocyte gate were used for analysis.")
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the Allophycocyanin conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control APC (open histogram) or Anti-Human CD27 APC (filled histogram). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0006.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the Biotin conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Anti-Human CD27 PE (left), and APC (right). Appropriate isotype controls were used (open histogram). Cells in the lymphocyte population were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0007.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the FITC conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Anti-Human CD19 APC and Mouse IgG1 K Isotype Control FITC (left) or Anti-Human CD27 FITC (right). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0008.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE conjugate of NBP1-43426. Analysis of human peripheral blood leukocytes using CD27 PE conjugate. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8 cells/test.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0009.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy5 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy5 (open histogram) or 0.25 ug of Anti-Human CD27 PE-Cy5 (filled histogram).=](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0010.jpg)